Abrilumab

Abrilumab
Monoclonal antibody
Type ?
Source Human
Target integrin alpha-4 beta-7
Clinical data
ATC code none
Identifiers
CAS Number 1342290-43-0
ChemSpider none
Chemical and physical data
Formula C6362H9806N1686O2014S52
Molar mass 143.8 kg/mol

Abrilumab[1] is a monoclonal antibody designed for the treatment of inflammatory bowel disease, ulcerative colitis, and Crohn's disease.[2]

This drug was developed by MedImmune.

References

  1. World Health Organization (2014). "International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 111" (PDF). WHO Drug Information. 28 (2).
  2. Statement On A Nonproprietary Name Adopted By The USAN Council - Abrilumab, American Medical Association.

External links


This article is issued from Wikipedia - version of the 7/18/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.